Delivery Order SPE2DB22D2206-SPE2DB25FKC08
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count units) valued at $2,707.41. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count) under a firm fixed-price contract valued at $13,888.78. The delivery order, which represents a child contract under AmerisourceBergen's larger prime vendor agreement, has an ultimate completion date of September 15, 2025. This award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count), with a contract ceiling value of $1,654.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,092.36 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This firm fixed-price contract, with an ultimate completion date of September 15, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's location in...
- The Defense Logistics Agency awarded a $7,142.54 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $7,553.07 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.90 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Contrave ER 8-90 mg tablets (120-unit quantity). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) with a contract value of $4,240.57. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is June 13, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $2,449.83 with a completion date of August 1, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office...